Savara Inc (SVRA) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $5.97
• Market Cap: $1.19B
• EPS: $-0.53
• 52-Week High: $7.00
• 52-Week Low: $1.89

Market Sentiment

Savara Inc currently has a Bullish sentiment score of 0.40.

About Savara Inc

Savara Inc. is a biopharmaceutical company headquartered in Austin, Texas, focused on developing innovative therapies for patients with rare lung diseases. With a commitment to addressing unmet medical needs in the field of respiratory health, Savara's pipeline includes promising candidates targeting various orphan indications. The company's strategic approach combines cutting-edge science with a patient-centric vision, positioning it as a key player in the lung disease therapeutic landscape.

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Savara Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does SVRA pay dividends?

Savara Inc (SVRA) does not currently pay a regular dividend.

What is SVRA's market cap?

Savara Inc (SVRA) has a market capitalization of $1.19B with a current stock price of $5.97.